• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of FDA advisory committee member positions vacant at the end of the month

Dictionary: Access to state-of-the-art, scientific expert advice to support agency decision making processes is imperative to the FDA advisory committee process. Having the fewest vacancies on our committees allows the agency to have ready access to those experts and supports the ability of FDA to meet its public health mission. For more information about FDA advisory committees, please visit http://www.fda.gov/AdvisoryCommittees/default.htm

Information is current as of March 31, 2014.

Fiscal Year - 2014

Skip graphic and jump to text data

TimeTargetPercent Vacant Positions
Oct 20131014
Nov 20131013
Dec 20131013
Jan 20141014
Feb 20141015
Mar 20141017
Apr 201410TBD
May 201410TBD
Jun 201410TBD
Jul 201410TBD
Aug 201410TBD
Sep 201410TBD

FY 2014 YTD: 17%

Number of FDA advisory committee member positions vacant at the end of the month

Fiscal Year - 2014
Skip graphic and jump to text data.

TimeTargetVacant Positions
Oct 2013N/A86
Nov 2013N/A78
Dec 2013N/A79
Jan 2014N/A87
Feb 2014N/A90
Mar 2014N/A103
Apr 2014N/ATBD
May 2014N/ATBD
Jun 2014N/ATBD
Jul 2014N/ATBD
Aug 2014N/ATBD
Sep 2014N/ATBD

FY 2014 YTD: 103

Total number of FDA advisory committee member positions at the end of the month

Fiscal Year - 2014
Skip graphic and jump to text data.

TimeTargetPositions
Oct 2013N/A620
Nov 2013N/A620
Dec 2013N/A620
Jan 2014N/A620
Feb 2014N/A607
Mar 2014N/A605
Apr 2014N/ATBD
May 2014N/ATBD
Jun 2014N/ATBD
Jul 2014N/ATBD
Aug 2014N/ATBD
Sep 2014N/ATBD

FY 2014 YTD: 605

Footnotes

  • CVM's Advisory Committee was terminated on September 30, 2013.

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.